Alan F. Holmer - 14 Jun 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role: Director
Signature: /s/ Meghan Houghton, attorney-in-fact for Alan Holmer
Issuer symbol: CRBP
Transactions as of: 14 Jun 2024
Net transactions value: +$50,010
Form type: 4
Filing time: 14 Jun 2024, 16:24:49 UTC
Previous filing: 03 Jun 2024
Next filing: 02 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRBP	Common Stock, par value $0.0001 per share	Options Exercise	$50,010	+1,667	+40%	$30.00	5,829	14 Jun 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRBP	Options to purchase common stock	Options Exercise	$0	-1,667	-100%	$0.000000^*	0	14 Jun 2024	Common Stock	1,667	$30.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amount includes 2,783 unvested RSUs that were granted on May 30, 2024 and will vest 100% on the one-year anniversary from the date of grant.
F2	The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested.